Charles A. Goldthwaite, Jr., Ph.D., is a science writer based in Nashville, TN.

During the previous 17 years, he has developed materials for technical and lay audiences across a broad range of scientific and biomedical topics.

He has developed Continuing Medical Education modules for state chapters of the American Academy of Family Physicians on issues related to diabetes and other metabolic disorders, cardiovascular disease, immunizations, depression, and pain management.

He also works with the National Cancer Institute to support large-scale technology initiatives focused on genomics (The Cancer Genome Atlas [TCGA], Therapeutically Applicable Research to Generate Effective Treatments [TARGET], Cancer Target Discovery and Development [CTD2], the Human Cancer Models Initiative [HCMI]) and proteomics (the Clinical Proteomic Tumor Analysis Consortium [CPTAC] and the Applied Proteogenomics Organizational Learning and Outcomes [APOLLO] network).

For the NIH, he has also written about biomarkers and surrogate endpoints in clinical research, stem cells/regenerative medicine, and national clinical research policy. He received his M.S. from Vanderbilt University and a Ph.D. from the University of Virginia.